Halliburton beats by $0.07, beats on revs
- Reports Q4 (Dec) earnings of $0.53 per share, excluding charges related to United States tax reform and Venezuela receivables, $0.07 better than the Capital IQ Consensus of $0.46; revenues rose 47.7% year/year to $5.94 bln vs the $5.63 bln Capital IQ Consensus.
- Completion and Production revenue in the fourth quarter of 2017 was $3.8 billion, an increase of $267 million, or 8%, from the third quarter of 2017, while operating income was $552 million, a sequential increase of $27 million, or 5%.
- Drilling and Evaluation revenue in the fourth quarter of 2017 was $2.1 billion, an increase of $229 million, or 12%, from the third quarter of 2017, while operating income was $291 million, an increase of $111 million, or 62%.
Official Now
Takeaway.com chief raises option of merger with Delivery Hero
The head of Dutch food delivery website Takeaway.com [TKWY:AS] this weekend raised the possibility of a merger with German rival Delivery Hero [DHER:DE], according to a newswire report.
Takeaway.com chief executive CEO Jitse Groen said in German newspaper Tagesspiegel that a combination with Delivery Hero might be an option, Reuters wrote. In terms of sector consolidation, he added, there is only room for one supplier in each country.
The CEO of Delivery Hero said on Monday that he believed there would be consolidation, though maybe not in Germany in the short term, according to the 22 January Reuters report.
Takeaway.com shares at midday on Monday were up almost 4% at EUR 47.75 apiece corresponding to a market cap of EUR 2.06bn.
Delivery Hero shares were up 4.5% at EUR 34.66 each for a market cap of EUR 5.96bn.
Link to original source (Reuters)
Link to original source (Tagesspiegel)
Prisa appoints Morgan Stanley and Banco Santander as EUR 562m capital increase underwriters
Promotora de Informaciones [BME:PRS] (Prisa) has appointed Morgan Stanley and Banco Santander as underwriters for its EUR 562m capital increase, El Confidencial reported citing financial sources. The two banks will underwrite the public offering with preferential rights that Prisa intends to carry out in the coming weeks to stabilise its financial situation.
Morgan Stanley and Santander will seek investors who would invest between EUR 170m and EUR 230m, which is equal to Prisa’s current market capitalization, the report noted. The capital raise has been increased from the initial EUR 450m to EUR 562m following the refusal by hedge funds to convert Prisa's debt into shares at a loss.
Prisa announced the transaction in October and seeks to close it by 31 March. Prisa’s main shareholders - AmberCapital (19%), the Polanco family (17.5%), HSBC (14.4%), Telefónica (13%), the Mexican investor Roberto Alcántara (8.9%), CaixaBank (4.9%) and Banco Santander (4.1%) - have to announce today (22 January) their commitment to the transaction.
Morgan Stanley and Santander are optimistic about the transaction, since the majority of the relevant shareholders will invest in the increase between 60 and 70% of the amount to be placed, the report added.
Sanofi generics Europe's first round auction held this week; valued at EUR 2bn – report (translated)
22 JAN 2018
The first round of auction for France-based pharma group Sanofi's [EPA:SAN] generics business in Europe takes place this week, French daily Les Echos reported.
The unsourced report said that investment fund KKR, Apax, CVC, PAI Partners, BC Partners, and Advent, are expected to submit an indicative offer for the business, valued at EUR 2bn.
Rothschild, JPMorgan and Morgan Stanley are handling the auction for Sanofi, the report claimed.